JP2021530543A5 - - Google Patents
Info
- Publication number
- JP2021530543A5 JP2021530543A5 JP2021503571A JP2021503571A JP2021530543A5 JP 2021530543 A5 JP2021530543 A5 JP 2021530543A5 JP 2021503571 A JP2021503571 A JP 2021503571A JP 2021503571 A JP2021503571 A JP 2021503571A JP 2021530543 A5 JP2021530543 A5 JP 2021530543A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- patient
- riluzole
- administered
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025026643A JP2025093952A (ja) | 2018-07-22 | 2025-02-21 | アルツハイマー病を処置するためのリルゾールプロドラッグの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862701814P | 2018-07-22 | 2018-07-22 | |
| US62/701,814 | 2018-07-22 | ||
| PCT/US2019/042718 WO2020023324A1 (en) | 2018-07-22 | 2019-07-20 | Use of riluzole prodrugs to treat alzheimer's disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025026643A Division JP2025093952A (ja) | 2018-07-22 | 2025-02-21 | アルツハイマー病を処置するためのリルゾールプロドラッグの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530543A JP2021530543A (ja) | 2021-11-11 |
| JPWO2020023324A5 JPWO2020023324A5 (https=) | 2022-02-15 |
| JP2021530543A5 true JP2021530543A5 (https=) | 2022-02-15 |
Family
ID=69181140
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503571A Pending JP2021530543A (ja) | 2018-07-22 | 2019-07-20 | アルツハイマー病を処置するためのリルゾールプロドラッグの使用 |
| JP2025026643A Pending JP2025093952A (ja) | 2018-07-22 | 2025-02-21 | アルツハイマー病を処置するためのリルゾールプロドラッグの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025026643A Pending JP2025093952A (ja) | 2018-07-22 | 2025-02-21 | アルツハイマー病を処置するためのリルゾールプロドラッグの使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12161633B2 (https=) |
| EP (1) | EP3823616A4 (https=) |
| JP (2) | JP2021530543A (https=) |
| KR (1) | KR20210034621A (https=) |
| CN (1) | CN112469408A (https=) |
| AU (1) | AU2019310013B2 (https=) |
| BR (1) | BR112021000768A2 (https=) |
| CA (1) | CA3107215A1 (https=) |
| EA (1) | EA202190308A1 (https=) |
| IL (1) | IL280177B2 (https=) |
| MX (2) | MX2021000515A (https=) |
| NZ (1) | NZ772009A (https=) |
| PH (1) | PH12021550043A1 (https=) |
| SG (1) | SG11202100385YA (https=) |
| WO (1) | WO2020023324A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230027189A (ko) * | 2020-06-24 | 2023-02-27 | 바이오하벤 테라퓨틱스 리미티드 | 강박 장애를 치료하기 위한 조성물 및 방법 |
| EP4240308A4 (en) * | 2020-10-05 | 2024-10-30 | Icahn School of Medicine at Mount Sinai | Riluzole for the treatment of alzheimer's disease |
| EP4277624B1 (en) * | 2021-01-18 | 2026-01-14 | Biohaven Therapeutics Ltd. | Troriluzole for use in the treatment of alzheimer's disease of mild severity |
| WO2022178425A1 (en) * | 2021-02-22 | 2022-08-25 | Yale University | Targeted bifunctional degraders |
| CN114344297B (zh) * | 2022-03-01 | 2024-05-14 | 暨南大学 | 利鲁唑在治疗少精症中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214663B2 (en) * | 2000-06-14 | 2007-05-08 | Medarex, Inc. | Tripeptide prodrug compounds |
| JP2008518935A (ja) * | 2004-11-01 | 2008-06-05 | セオ ホン ユー | 筋萎縮性側索硬化症の神経退行を減少させるための方法及び組成物 |
| FR2957077B1 (fr) * | 2010-03-02 | 2012-04-13 | Univ Dauvergne Clermont I | Utilisation du riluzole pour traiter ou prevenir les effets indesirables d'agents anti-cancereux |
| EP3079692A4 (en) | 2013-12-09 | 2017-10-18 | Thomas Jefferson University | Novel methods of treating a neurodegenerative disease in a mammal in need thereof |
| WO2016085998A1 (en) * | 2014-11-26 | 2016-06-02 | Medicinova, Inc. | Combination of ibudilast and riluzole and methods of using same |
| RS62915B1 (sr) * | 2015-03-03 | 2022-03-31 | Biohaven Therapeutics Ltd | Prolekovi riluzola i njihova primena |
| WO2017201502A1 (en) * | 2016-05-20 | 2017-11-23 | Biohaven Pharmaceutical Holding Company Ltd. | Use of glutamate modulating agents with immunotherapies to treat cancer |
| WO2018031707A1 (en) * | 2016-08-10 | 2018-02-15 | Biohaven Pharmaceutical Holding Company Ltd. | Acyl benzo[d]thiazol-2-amine and their methods of use |
| AU2019223014B2 (en) * | 2018-02-21 | 2024-10-17 | Orphai Therapeutics Inc. | Combination therapy with apilimod and glutamatergic agents |
| EP4277624B1 (en) * | 2021-01-18 | 2026-01-14 | Biohaven Therapeutics Ltd. | Troriluzole for use in the treatment of alzheimer's disease of mild severity |
-
2019
- 2019-07-20 WO PCT/US2019/042718 patent/WO2020023324A1/en not_active Ceased
- 2019-07-20 CA CA3107215A patent/CA3107215A1/en active Pending
- 2019-07-20 JP JP2021503571A patent/JP2021530543A/ja active Pending
- 2019-07-20 US US17/261,057 patent/US12161633B2/en active Active
- 2019-07-20 EA EA202190308A patent/EA202190308A1/ru unknown
- 2019-07-20 KR KR1020217004639A patent/KR20210034621A/ko not_active Ceased
- 2019-07-20 IL IL280177A patent/IL280177B2/en unknown
- 2019-07-20 EP EP19841953.3A patent/EP3823616A4/en active Pending
- 2019-07-20 NZ NZ772009A patent/NZ772009A/en unknown
- 2019-07-20 AU AU2019310013A patent/AU2019310013B2/en active Active
- 2019-07-20 BR BR112021000768-7A patent/BR112021000768A2/pt unknown
- 2019-07-20 CN CN201980048687.7A patent/CN112469408A/zh active Pending
- 2019-07-20 SG SG11202100385YA patent/SG11202100385YA/en unknown
- 2019-07-20 MX MX2021000515A patent/MX2021000515A/es unknown
-
2021
- 2021-01-07 PH PH12021550043A patent/PH12021550043A1/en unknown
- 2021-01-14 MX MX2024010655A patent/MX2024010655A/es unknown
-
2025
- 2025-02-21 JP JP2025026643A patent/JP2025093952A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530543A5 (https=) | ||
| US11957688B2 (en) | Combination therapy with apilimod and glutamatergic agents | |
| JP5911929B2 (ja) | 特定の癌の治療のためのｒｄｅａ１１９／ｂａｙ８６９７６６を含む組み合わせ医薬 | |
| JP2020514318A5 (https=) | ||
| JP2021534160A5 (https=) | ||
| ZA200802811B (en) | Therapy for the treatment of disease | |
| JP2021502392A5 (https=) | ||
| JP2017511339A5 (https=) | ||
| RU2014150942A (ru) | Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона | |
| JP2011525185A5 (https=) | ||
| JP2014512355A5 (https=) | ||
| JP2016507500A5 (https=) | ||
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JPWO2019241442A5 (https=) | ||
| JP2022169780A5 (https=) | ||
| JPWO2020023324A5 (https=) | ||
| JP2021530568A5 (https=) | ||
| JP2008501023A (ja) | 小児患者での癌の治療 | |
| MX2010006310A (es) | O-desmetil-venlafaxina para el tratamiento de transtorno depresivo mayor. | |
| WO2014056566A1 (en) | Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with a mek inhibitor | |
| TWI837197B (zh) | 胺基甲酸酯化合物於預防、緩解或治療糖尿病周邊神經病變或化療誘發的周邊神經病變的用途 | |
| JP2020503318A5 (https=) | ||
| JPWO2021087432A5 (https=) | ||
| CN114432446B (zh) | 抗组胺药在制备抗肿瘤药物中的应用 | |
| WO2024104561A1 (en) | Therapeutic combinations of capivasertib and venetoclax |